The RNA-binding protein RBPMS inhibits smooth muscle cell–driven vascular remodeling in atherosclerosis and vascular injury
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2415933122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Jianlin Du und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. Hauptthemen laut MEDLINE: Atherosclerosis, Myocytes, Smooth Muscle, Muscle, Smooth, Vascular, Vascular Remodeling. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Atherosclerosis and vessel wall trauma induce vascular smooth muscle cell (VSMC) phenotypic modulation, leading to plaque cap growth and postintervention restenosis. Our systems biology approach identified RNA binding protein, mRNA processing factor ( RBPMS ) as a conserved, VSMC-specific gene associated with VSMC modulation in atherosclerosis. RBPMS gene expression positively correlates with VSMC contractile markers in human and murine atherosclerotic arteries as well as in two vascular injury models during the postinjury intimal hyperplasia phase. RBPMS promotes contractile VSMC differentiation, reduces plaque cap development in high-fat diet-fed apolipoprotein E-null ( ApoE −/− ) murine atherosclerotic arteries, and inhibits intimal hyperplasia. Mechanistically, the RBPMS protein interacts with the myocardin ( MYOCD ) pre-mRNA and enhances MYOCD_v3 / MYOCD_v1 transcript balance through alternative exon 2a splicing. RBPMS promotes the VSMC contractile phenotype and reduces their fibroproliferative activity in a MYOCD_v3a-dependent manner. RBPMS enhances Myocd_v3 / Myocd_v1 transcript balance in both atherosclerotic and injured vessels. RBPMS may inhibit VSMC-driven plaque cap development and intervention-induced restenosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
- Department of Nephrology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
- Precision Medicine Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Municipality Clinical Research Center for Geriatrics and Gerontology, Chongqing 400016, China.
- Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
- Chongqing Key Laboratory of Ultrasound Molecular Imaging and Therapy, Chongqing 400016, China.
- Department of Rehabilitation and Pain Medicine, The Ninth People's Hospital of Chongqing, Chongqing 400700, China.
ORCID-Profile: N D Melgiri, Yang Sun
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
Zitieren
APA
Du, J., Yuan, X., Wang, J., Zhang, L., Tan, F., Hu, T., Li, X., Liu, F., Ran, H., Wang, Z., Li, Y., Feng, Y., Melgiri, N. D., Cao, Y., Jiang, L., Huang, R., & Sun, Y. (2025). The RNA-binding protein RBPMS inhibits smooth muscle cell–driven vascular remodeling in atherosclerosis and vascular injury. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2415933122
Vancouver
Du J, Yuan X, Wang J, Zhang L, Tan F, Hu T, et al. The RNA-binding protein RBPMS inhibits smooth muscle cell–driven vascular remodeling in atherosclerosis and vascular injury. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2415933122
BibTeX
@article{Du2025,
author = {Du, Jianlin and Yuan, Xin and Wang, Jiajia and Zhang, Lujun and Tan, Fangyan and Hu, Tianyang and Li, Xingsheng and Liu, Fan and Ran, Haitao and Wang, Zhigang and Li, Yongyong and Feng, Yuxing and Melgiri, N D and Cao, Yu and Jiang, Lihong and Huang, Rongzhong and Sun, Yang},
title = {The RNA-binding protein RBPMS inhibits smooth muscle cell–driven vascular remodeling in atherosclerosis and vascular injury},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2415933122}
}
EUVIMED